GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » 5-Year ROIIC %

Vectus Biosystems (ASX:VBS) 5-Year ROIIC % : 3,213.37% (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Vectus Biosystems's 5-Year ROIIC % for the quarter that ended in Jun. 2023 was 3,213.37%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Vectus Biosystems's 5-Year ROIIC % or its related term are showing as below:

ASX:VBS's 5-Year ROIIC % is ranked better than
97.77% of 1302 companies
in the Biotechnology industry
Industry Median: -22.27 vs ASX:VBS: 3213.37

Vectus Biosystems 5-Year ROIIC % Historical Data

The historical data trend for Vectus Biosystems's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems 5-Year ROIIC % Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only - -17.98 -11.21 3,213.37 -1,354.66

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.21 - 3,213.37 - -1,354.66

Competitive Comparison of Vectus Biosystems's 5-Year ROIIC %

For the Biotechnology subindustry, Vectus Biosystems's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's 5-Year ROIIC % falls into.



Vectus Biosystems 5-Year ROIIC % Calculation

Vectus Biosystems's 5-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -4.598 (Jun. 2023) - -2.573579 (Jun. 2018) )/( 1.425 (Jun. 2023) - 1.488 (Jun. 2018) )
=-2.024421/-0.063000000000001
=3,213.37%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Vectus Biosystems  (ASX:VBS) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Vectus Biosystems 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems Business Description

Traded in Other Exchanges
N/A
Address
26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. It operates in one segment, being pharmaceutical research and development.

Vectus Biosystems Headlines

No Headlines